Ticker Symbol: AEZS
Aeterna Zentaris Inc.
$0.53 - 20-10-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Canada
Currency:
USD
Asset
Type: Common Stock
CIK:0001113423
Company Profile
æterna zentaris inc. (tsx: aez, nasdaq: aezs) is a global biopharmaceutical company focused on endrocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. æterna zentaris inc. (tsx: aez, nasdaq: aezs) est une société biopharmaceutique internationale, spécialisée dans la découverte, le développement et la commercialisation de thérapies en endocrinologie et en oncologie.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 41St
Website: http://www.aezsinc.com/
CEO: Klaus Paulini
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $1.56
Change:
-$0.12
(
-7.14%)
Days Range: $1.56 - $1.81
Beta: 0.91
52wk. High: $4.40
52wk. Low: $1.56
Ytd. Change -58.09%
50 Day Moving Average: $2.27
200 Day Moving Average: $2.72
Shares Outstanding: 4855880
Valuation
Market Cap: 757.5M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A